What is Acadia Pharmaceuticals's free cash flow margin?

Acadia Pharmaceuticals (ACAD) reported free cash flow margin of 18.9% in Q3 2025.

What is the long-term trend for Acadia Pharmaceuticals's free cash flow margin?

Over 2 years (2020 to 2022), Acadia Pharmaceuticals's free cash flow margin has grown at a -17.7% compound annual growth rate (CAGR), from -32.5% to -22%.

What does free cash flow margin mean?

Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.

Acadia Pharmaceuticals ACAD Free cash flow margin

Free cash flow margin at other companies

BiogenBIIB

24.4%-0.4pp

Neurocrine BiosciencesNBIX

26.8%+6.4pp

Catalyst PharmaceuticalCPRX

34.9%-15.2pp

PTC TherapeuticsPTCT

39.1%+32.8pp

BridgeBio PharmaBBIO

-76.8%—

Arrowhead ResearchARWR

1.8%+0.9pp

Other financials

Income statement

See full

Revenue$268.1M+9.7%

Gross profit$243.3M+8.6%

Operating income-$4.6M-124%

Net income$3.6M-80.8%

EPS (diluted)$0.02-81.8%

Balance sheet

See full

Cash & equivalents$282.2M+29.6%

Total debt$50.8M-9.3%

Total equity$1.2B+63.1%

Total assets$1.6B+41.8%

Cash flow

See full

Operating cash flow$34.0M+67.2%

CapEx$5.2M—

Free cash flow$28.8M+41.6%

Valuation

See full

Market cap$3.7B+37.0%

Enterprise value$3.47B+36.6%

P/E9.9×-2.0×

P/S3.4×+0.7×

Profitability

See full

Gross margin91.5%-0.6pp

Operating margin7.4%-16.2pp

Net margin34.3%+11.3pp

Returns & leverage

See full

Return on equity37.3%+0.1pp

Debt / equity0×0.0×

Current ratio3.6×+0.7×

Where this comes from

Calculated from Acadia Pharmaceuticals’s reported figures.

free cash flow/total revenue=18.9%

Based on trailing twelve months.

The official record: Acadia Pharmaceuticals’s 10-Q, filed November 6, 2025, on SEC EDGAR. View the filing →

Ask your AI about Acadia Pharmaceuticals's free cash flow margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Acadia Pharmaceuticals's free cash flow margin?: Acadia Pharmaceuticals (ACAD) reported free cash flow margin of 18.9% in Q3 2025.
What is the long-term trend for Acadia Pharmaceuticals's free cash flow margin?: Over 2 years (2020 to 2022), Acadia Pharmaceuticals's free cash flow margin has grown at a -17.7% compound annual growth rate (CAGR), from -32.5% to -22%.
What does free cash flow margin mean?: Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.